Immunohematology reagents and supplies
Active Awarded
- Contract number
- HT941026FE080
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $61,641.98 Current, with exercised options
- $316,733.14 Potential, with all options
- Completion date 5% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Werfen USA LLC on August 18, 2026, with a ceiling value of $316,733.14, under the Invitro Diagnostics, Reagents, Test (FSS-65-VII) parent schedule. The order is a firm fixed price award for immunohematology reagents and supplies. Performance is at Bedford, MA 01730, from award through September 30, 2031. No set-aside was used.
Quick answers
Who was awarded contract HT941026FE080?
HT941026FE080 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on August 18, 2026.
How much is contract HT941026FE080 worth?
The government has obligated $0 on HT941026FE080. Its current value, with exercised options, is $61,642. Its potential value, with all options, is $316,733.
Is contract HT941026FE080 an order under another contract?
Yes. HT941026FE080 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract HT941026FE080 competed?
The extent of competition for HT941026FE080 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award